Phase II Study of Whole or Partial Parotid Sparing Intensity Modulated Radiotherapy in Patients With Head and Neck Cancers

NCT02068313 · clinicaltrials.gov ↗

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

RADIATION: Toxicity and outcome measures of IMRT

Sponsor

Royal Marsden NHS Foundation Trust